Sherry X. Yu

Statistics

Publications

Citations

341

H-Index

Active since

2007

Affiliations

Science Applications International Corporation (United States)(Current)

Frederick National Laboratory for Cancer Research

National Cancer Institute

Sherry X. Yu is an author at Science Applications International Corporation (United States) specializing in apoptosis, pharmacology, and molecular oncology.

Publications per year

2007–2010

Publications

Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC

Luke H. Stockwin, Sherry X. Yu, Suzanne Borgel et al. · International Journal of Cancer · 2010 · 156 citations

Medicine, Oncology, Pharmacology +17

Artemisinin dimer anticancer activity correlates with heme‐catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction

Luke H. Stockwin, Bingnan Han, Sherry X. Yu et al. · International Journal of Cancer · 2009 · 103 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Proteomic Analysis Identifies Oxidative Stress Induction by Adaphostin

Luke H. Stockwin, Maja A. Bumke, Sherry X. Yu et al. · Clinical Cancer Research · 2007 · 53 citations

Life Sciences, Biochemistry, Pharmacology +17

ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC

Luke H. Stockwin, Sherry X. Yu, Howard Stotler et al. · BMC Cancer · 2009 · 29 citations · Full text

Medicine, Oncology, Pharmacology +16

1–4 of 4